In the News

Marsha Gentner Surveys Cannabis Legalization Landscape in Life Sciences IP Review

October 24, 2018

Marsha G. Gentner, Washington, D.C.-based senior counsel in Dykema’s Intellectual Property Practice Group, was interviewed at length for the Life Sciences IP Review article, “Mulling the Future for Marijuana IP.”

The article discusses the legal status of marijuana in various countries, paying special attention to the situation in the United States, where federal and state laws have been growing apart in permissiveness. Gentner underlines the resultant complications for trademark applications, noting that some cannabis-associated patent filings are allowable. She describes the current regulatory status, the possible impact on interstate commerce of Canada’s recent legalization of recreational marijuana, and concludes that a federal trend towards more leniency is inevitable.

Subscribers to Life Sciences IP Review will find the article here.